These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 19691205)

  • 41. Jaw osteonecrosis associated with intravenous bisphosphonate: is incidence reduced after adoption of dental preventive measures?
    Fusco V; Baraldi A; Loidoris A; Ciuffreda L; Galassi C; Goia F; Scoletta M; Berrone S; Benech A; Ortega C; Berruti A;
    J Oral Maxillofac Surg; 2009 Aug; 67(8):1775. PubMed ID: 19615599
    [No Abstract]   [Full Text] [Related]  

  • 42. Bisphosphonate therapy and dental treatment.
    Phillips G
    J Indiana Dent Assoc; 2007-2008 Winter; 86(4):4-8. PubMed ID: 18363257
    [No Abstract]   [Full Text] [Related]  

  • 43. Frequency estimates of BRON--is it really zero?
    Dodson TB; Chuang SK
    J Oral Maxillofac Surg; 2008 Jul; 66(7):1558; author reply 1558-9. PubMed ID: 18571053
    [No Abstract]   [Full Text] [Related]  

  • 44. Bisphosphonate therapy and dental treatment.
    Phillips G
    J Mich Dent Assoc; 2009 Aug; 91(8):40, 42-5. PubMed ID: 19722373
    [No Abstract]   [Full Text] [Related]  

  • 45. Diabetes and the risk of osteonecrosis of the jaw.
    Favus MJ
    J Clin Endocrinol Metab; 2007 Mar; 92(3):817-8. PubMed ID: 17341579
    [No Abstract]   [Full Text] [Related]  

  • 46. Osteonecrosis of the jaw: new developments in an old disease.
    Khan A
    J Rheumatol; 2008 Apr; 35(4):547-9. PubMed ID: 18398947
    [No Abstract]   [Full Text] [Related]  

  • 47. Fosamax and osteonecrosis of the jaw--important questions and answers.
    Wynn RL
    Gen Dent; 2008; 56(4):315-7. PubMed ID: 19284187
    [No Abstract]   [Full Text] [Related]  

  • 48. Bisphosphonate-associated osteonecrosis: experiences in a private practice.
    Marder MZ; Marder RW
    Dent Today; 2008 Oct; 27(10):99-100, 102-3; quiz 103, 98. PubMed ID: 18935863
    [No Abstract]   [Full Text] [Related]  

  • 49. Persisting alveolar sockets-a radiologic symptom of BP-ONJ?
    Groetz KA; Al-Nawas B
    J Oral Maxillofac Surg; 2006 Oct; 64(10):1571-2. PubMed ID: 16982320
    [No Abstract]   [Full Text] [Related]  

  • 50. I've heard that bisphosphonate medications used for osteoporosis can affect a person's jaw. Can you tell me more?
    Mayo Clin Womens Healthsource; 2008 Sep; 12(9):8. PubMed ID: 18667975
    [No Abstract]   [Full Text] [Related]  

  • 51. Serum CTX testing.
    Schwartz HC
    J Oral Maxillofac Surg; 2008 Jun; 66(6):1319-20; author reply 1320. PubMed ID: 18486810
    [No Abstract]   [Full Text] [Related]  

  • 52. Oral osteonecrosis associated with the use of zoledronic acid: first case of a patient with advanced pancreatic cancer and bone metastases.
    Smith A; Kressley A; Saif MW
    JOP; 2009 Mar; 10(2):212-4. PubMed ID: 19287122
    [No Abstract]   [Full Text] [Related]  

  • 53. Bisphosphonate-related osteonecrosis of the jaw in cancer patients and hyperbaric oxygen therapy.
    Erkan M; Bilgi O; Mutluoğlu M; Uzun G
    JOP; 2009 Sep; 10(5):579-80; author reply 581-2. PubMed ID: 19734644
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment protocols of bisphosphonate-related osteonecrosis of the jaws.
    Kyrgidis A; Koloutsos G; Vahtsevanos K
    Head Neck; 2009 Aug; 31(8):1112-3; author reply 1113-4. PubMed ID: 19572289
    [No Abstract]   [Full Text] [Related]  

  • 55. Bisphosphonates and orthodontics.
    Goss AN
    Aust Orthod J; 2008 May; 24(1):56-7. PubMed ID: 18649566
    [No Abstract]   [Full Text] [Related]  

  • 56. Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw.
    Ruggiero SL
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):479-87. PubMed ID: 26293329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sinus tracts--an early sign of bisphosphonate-associated osteonecrosis of the jaws?
    Mawardi H; Treister N; Richardson P; Anderson K; Munshi N; Faiella RA; Woo SB
    J Oral Maxillofac Surg; 2009 Mar; 67(3):593-601. PubMed ID: 19231786
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.
    ; Khosla S; Burr D; Cauley J; Dempster DW; Ebeling PR; Felsenberg D; Gagel RF; Gilsanz V; Guise T; Koka S; McCauley LK; McGowan J; McKee MD; Mohla S; Pendrys DG; Raisz LG; Ruggiero SL; Shafer DM; Shum L; Silverman SL; Van Poznak CH; Watts N; Woo SB; Shane E
    J Oral Maxillofac Surg; 2008 Jun; 66(6):1320-1; author reply 1321-2. PubMed ID: 18486811
    [No Abstract]   [Full Text] [Related]  

  • 59. Osteonecrosis of the jaw and biomarkers: what do we tell our patients?
    Koka S
    Int J Oral Maxillofac Implants; 2008; 23(2):179-80. PubMed ID: 18548914
    [No Abstract]   [Full Text] [Related]  

  • 60. [The return of phossy jaw?].
    Broome M; Jaques B; Madrid C
    Rev Stomatol Chir Maxillofac; 2008 Jun; 109(3):203-5. PubMed ID: 18533213
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.